Fennec Pharmaceuticals Inc. · NASDAQ:FENC

Hackman Jeffrey S. received 1,159 Fennec Pharmaceuticals Inc. shares as an award (Form 4)

Traded Jul 31, 2026 · Filed Aug 3, 2026

On Jul 31, 2026, Hackman Jeffrey S. (Director, Chief Executive Officer) received 1,159 Fennec Pharmaceuticals Inc. shares as an award, leaving 65,143 shares. Filed Aug 3, 2026 (Form 4).

Awarded
1,159 shares
Holding after
65,143 shares
Trading plan
No
Role
Director, Chief Executive Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 31, 2026Common SharesAward1,15965,143Direct

Source

View original at SEC

Related